EVERSEPT PARTNERS, LP – Aerie Pharmaceuticals, Inc. Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$3.87M
portfolio value
Aerie Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 256.28K shares | 3.87M | $15.13 | 256.28K |
| Q2 2019 | share | Decrease | -100.00% | -114.77K shares | -5.45M | $29.55 | 0 |
| Q1 2019 | share | Decrease | -50.69% | -118.01K shares | -2.95M | $47.5 | 114.77K |
| Q4 2018 | share | Increase | +92.85% | 112.07K shares | 974K | $36.1 | 232.79K |
| Q3 2018 | share | Decrease | -46.80% | -106.19K shares | -7.89M | $61.55 | 120.71K |
| Q2 2018 | share | Increase | +7.65% | 16.12K shares | 3.89M | $67.55 | 226.90K |
| Q1 2018 | share | Decrease | -12.71% | -30.70K shares | -2.99M | $54.25 | 210.77K |
| Q4 2017 | share | Increase | 0.00% | 241.48K shares | 14.42M | $59.75 | 241.48K |